CLOSEClose International Edition Menu

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Owners of intellectual property rights (IPR) can breathe a sigh of relief. On 29 April, 2004, the European Court of Justice issued its judgment in the controversial IMS Health case, confirming its previous position that IPR owners are generally free to exercise their exclusive rights, and that only in very narrowly defined “exceptional circumstances” would a refusal to license one’s IPR amount to an abuse of a dominant position under European Commission (EC) competition law. With this judgment, the court firmly rejected the EC’s attempts to make the exceptional circumstances of compulsory licensing increasingly unexceptional.

This premium content is reserved for International Subscribers.


  • Customized news by region including UK, Asia, Europe, Latin America, Middle East, Africa, and North America
  • Cutting-edge research such as UK Top 100, China 45, and Asia 50
  • Get the inside track on the biggest breaking stories that delve deep into the issues behind the headlines
  • Comprehensive coverage of the dynamic legal market from people moves to the major international jurisdictions
  • Global view into how legal tech, business of law, in-house and regulatory environments are intersecting worldwide

Already a subscriber? International Newsletters & Briefings

Sign Up Today and Never Miss Another Story.

Sign up for an unlimited number of complementary newsletters, alerts, and International Briefings. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 American Lawyer Media International, LLC. All Rights Reserved.